◆ Contrarian Corpus
Campaigns / Pershing Square → Allergan, Inc.
Pershing Square vs. Allergan, Inc.

Allergan, Inc. · AGN

1 deck published between 2014-04-22 and 2014-04-22 — 110 pages, 110 analysed slides total. Outcome: lost.

initial thesis

Timeline

Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.

  1. 2014-04-22 initial thesis

    2014 04 Pershing Square Allergan Valeant Presentation Apr 2014

    110pp · full_deck

    Allergan shareholders should accept Valeant's bid: Valeant is an 'Outsider'-style acquirer (25x TSR under Pearson) whose lean R&D and platform M&A will compound Val-gan's value far beyond Allergan standalone.